Unravelling the Mechanism of Methylophiopogonanone A Against Esophageal Squamous Cell Carcinoma Based on Network Pharmacology and Molecular Docking
MO-A can impede ESCC growth by triggering cell cycle G2/M arrest, posi-tioning it as a novel and promising phytocompound for ESCC therapy.
Authors
- Siliang Wang (ORCID: https://orcid.org/0000-0003-1228-869X)
- Yu‐Shui Ma (ORCID: https://orcid.org/0000-0002-5728-7458)
- Wen‐Lian Chen (ORCID: https://orcid.org/0000-0002-1359-2549)
- Miaomiao Zheng (ORCID: https://orcid.org/0000-0002-4712-1155)
- Jia Wu
- C.Jin Qin
Institutions
- Jiading District Central Hospital (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Current Cancer Drug Targets
- Published
- 2025-09-25
- DOI
- https://doi.org/10.2174/0115680096387327250906212020
- Primary Topic
- Inflammatory mediators and NSAID effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00